Table 3.

Uni- and multivariate analyses

Variables	Univariate odds ratio (95%CI)	P-value	Multivariate odds ratio (95%CI)	P-value
Sex
Male vs. Female	1.395 (0.762-2.553)	0.279
Age
≧70 vs. <70	1.018 (0.546-1.899)	0.955
≧80 vs. <80	1.648 (0.837-3.245)	0.147
Etiology
HCV vs. non-HCV	0.471 (0.249-0.893)	0.020	0.436 (0.175-1.087)	0.075
HBV vs. non-HBV	1.944 (0.778-4.858)	0.150
HBV/HCV vs. non-virus	0.658 (0.323-1.342)	0.248
Previous treatment
Yes vs. No	1.197 (0.636-2.247)	0.578
Child Pugh
A vs. B	2.002 (1.026-3.905)	0.040	3.727 (1.344-10.338)	0.011
BCLC
0/A vs. B/C	2.799 (1.508-5.196)	<0.001	3.823 (0.949-15.402)	0.059
AST
>40 vs. ≦40	0.506 (0.269-0.951)	0.033	0.403 (0.169-0.962)	0.041
ALT
>40 vs. ≦40	0.915 (0.502-1.666)	0.770
Alb
<3.6 vs. ≧3.6	0.288 (0.155-0.534)	<0.001	0.713 (0.304-1.671)	0.437
Number
1 vs. ≧2	1.592 (0.768-3.300)	0.209
1-3 vs. ≧4	1.676 (0.929-3.024)	0.085	0.302 (0.073-1.256)	0.100
1-5 vs. ≧6	1.702 (0.906-3.199)	0.097
Size
>20 vs. ≦20	0.393 (0.214-0.721)	0.002
>30 vs. ≦30	0.240 (0.113-0.509)	<0.001	0.267 (0.098-0.729)	0.010
AFP
≧50 vs. <50	0.313 (0.160-0.613)	<0.001
≧100 vs. <100	0.248 (0.114-0.539)	<0.001	0.256 (0.101-0.649)	0.004
DCP
≧100 vs. <100	0.582 (0.323-1.051)	0.071
≧500 vs. <500	0.294 (0.149-0.580)	<0.001	0.477 (0.201-1.131)	0.093
TACE procedure
DCB-TACE vs. cTACE	0.357 (0.192-0.663)	<0.001	0.128 (0.047-0.344)	<0.001

Note. HCV; hepatitis C virus, HBV; hepatitis B virus, BCLC; Barcelona Clinic Liver Cancer, AST; aspartate aminotransferase, ALT; alanine transaminase, Alb; albumin, AFP; alpha fetoprotein, DCP; des-gamma-carboxy prothrombin.